PyInvesting

Market research

NRC National Research Corp

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
485M
P/E ratio
91.33
Analyst target
26
Dividend yield
2.7%
Beta
0.37

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

National Research Corporation is currently in a long term downtrend where the price is trading 3.6% below its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.3.

National Research Corporation's total revenue rose by 6.6% to $35M since the same quarter in the previous year.

Its net income has dropped by 5.6% to $8M since the same quarter in the previous year.

Finally, its free cash flow grew by 36.9% to $15M since the same quarter in the previous year.

Based on the above factors, National Research Corporation gets an overall score of 3/5.